Lara Schneider
- Psychiatry and Mental health top 2%
- Pharmacology top 5%
- Physiology top 10%
- Neurology top 10%
- Economics and Econometrics top 10%
- Co-authors
- Jason T. OlinSteven H. FerrisFrederick A. SchmittRachelle S. DoodyRonald G. ThomasChristopher M. ClarkMichael GrundmanBarry Reisberg
- Topics
- Dementia and Cognitive Impairment Research (2 papers)Health Systems, Economic Evaluations, Quality of Life (2 papers)Cholinesterase and Neurodegenerative Diseases (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Lara Schneider
6 papers receiving 748 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Psychiatry and Mental health 481
- Pharmacology 275
- Physiology 241
- Neurology 107
- Economics and Econometrics 98
Countries citing papers authored by Lara Schneider
This map shows the geographic impact of Lara Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Schneider more than expected).
Fields of papers citing papers by Lara Schneider
This network shows the impact of papers produced by Lara Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Schneider. The network helps show where Lara Schneider may publish in the future.
Co-authorship network of co-authors of Lara Schneider
This figure shows the co-authorship network connecting the top 25 collaborators of Lara Schneider. A scholar is included among the top collaborators of Lara Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Schneider. Lara Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials | 1 |
| 2 | 83 | |
| 3 | Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Changebreakdown → | 528 |
| 4 | Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. | 25 |
| 5 | A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. | 39 |
| 6 | The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. | 99 |
About Lara Schneider
Lara Schneider is a scholar working on Psychiatry and Mental health, Complementary and alternative medicine and Philosophy, having authored 6 papers that have together received 775 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Psychiatry and Mental health (481 citations), Geriatrics and Gerontology (68 citations) and Pharmacology (275 citations). Lara Schneider has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jason T. Olin, Steven H. Ferris, Frederick A. Schmitt, Rachelle S. Doody, Ronald G. Thomas, Christopher M. Clark, Michael Grundman, Barry Reisberg, John C. Morris and L. J. Thal. Their work appears in journals such as Cochrane Database of Systematic Reviews, Alzheimer Disease & Associated Disorders and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.